Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost
Vaishali Shukla, Enrique Seoane‐Vazquez, Souhiela Fawaz, et al.
Human Gene Therapy Clinical Development (2019) Vol. 30, Iss. 3, pp. 102-113
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Promises and challenges of adoptive T-cell therapies for solid tumours
Matteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 11, pp. 1759-1776
Open Access | Times Cited: 201
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care
Marian L. Henderson, Jacob K. Zieba, Xiaopeng Li, et al.
BioTech (2024) Vol. 13, Iss. 1, pp. 1-1
Open Access | Times Cited: 18
Advanced gene nanocarriers/scaffolds in nonviral-mediated delivery system for tissue regeneration and repair
Wanheng Zhang, Yan Hou, Shiyi Yin, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Volumetric Additive Manufacturing for Cell Printing: Bridging Industry Adaptation and Regulatory Frontiers
Vidhi Mathur, Valerian T. D’Souza, Varadharajan Srinivasan, et al.
ACS Biomaterials Science & Engineering (2025) Vol. 11, Iss. 1, pp. 156-181
Open Access | Times Cited: 2
qPCR and qRT-PCR analysis: Regulatory points to consider when conducting biodistribution and vector shedding studies
Haiyan Ma, Kristin N. Bell, Rossi N. Loker
Molecular Therapy — Methods & Clinical Development (2020) Vol. 20, pp. 152-168
Open Access | Times Cited: 88
Current standards and ethical landscape of engineered tissues—3D bioprinting perspective
Muthu Parkkavi Sekar, Harshavardhan Budharaju, Allen Zennifer, et al.
Journal of Tissue Engineering (2021) Vol. 12
Open Access | Times Cited: 80
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Brian Godman, Andrew Hill, Steven Simoens, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 21, Iss. 4, pp. 527-540
Open Access | Times Cited: 63
Approaches for corneal endothelium regenerative medicine
Pere Català, Gilles Thuret, Heli Skottman, et al.
Progress in Retinal and Eye Research (2021) Vol. 87, pp. 100987-100987
Open Access | Times Cited: 63
Commercialization and regulation of regenerative medicine products: Promises, advances and challenges
Nima Beheshtizadeh, Maliheh Gharibshahian, Zahra Pazhouhnia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113431-113431
Open Access | Times Cited: 39
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
Hélène Banoun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10514-10514
Open Access | Times Cited: 26
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies
Logan Thrasher Collins, Selvarangan Ponnazhagan, David T. Curiel
ACS Synthetic Biology (2023) Vol. 12, Iss. 1, pp. 17-26
Open Access | Times Cited: 24
Gene Therapy in Hemophilia: Recent Advances
E. Carlos Rodríguez‐Merchán, Juan A. De Pablo-Moreno, Antonio Liras
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7647-7647
Open Access | Times Cited: 42
Immobilization of Growth Factors for Cell Therapy Manufacturing
Daniela Enriquez-Ochoa, Pedro Robles-Ovalle, Karla Mayolo‐Deloisa, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 43
Gene Therapy Strategies Targeting Aging-Related Diseases
Jingyu Yu, Tianwen Li, Jianhong Zhu
Aging and Disease (2022)
Open Access | Times Cited: 28
Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials
Federica Fogacci, Giuseppe Danilo Norata, Peter P. Tóth, et al.
Current Atherosclerosis Reports (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 34
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
Elisabete Gonçalves
The European Journal of Health Economics (2021) Vol. 23, Iss. 2, pp. 155-163
Open Access | Times Cited: 28
Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
Isabelle Adant, Matthew Bird, Bram Decru, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101537-101537
Open Access | Times Cited: 22
Future of genetic therapies for rare genetic diseases: what to expect for the next 15 years?
Luiza Amara Maciel Braga, Carlos Gilbert Conte Filho, Fábio Batista Mota
Therapeutic Advances in Rare Disease (2022) Vol. 3
Open Access | Times Cited: 21
CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions
A. Abraham, Panagiotis Maghsoudlou, David A. Copland, et al.
Frontiers in Ophthalmology (2023) Vol. 3
Open Access | Times Cited: 12
Improved Recombinant Adeno-Associated Viral Vector Production via Molecular Evolution of the Viral Rep Protein
Thomas Steininger, Veronika Öttl, Linda E. Franken, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1319-1319
Open Access
The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
Lorenzo Piemonti, Hanne Scholz, Dide de Jongh, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 9
Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
Buthainah Ghanem, Enrique Seoane‐Vazquez, Lawrence M. Brown, et al.
Medical Care (2023) Vol. 61, Iss. 7, pp. 438-447
Closed Access | Times Cited: 8
What is the educational value and clinical utility of artificial intelligence for intraoperative and postoperative video analysis? A survey of surgeons and trainees
M. Hameed, Simon Laplante, Caterina Masino, et al.
Surgical Endoscopy (2023) Vol. 37, Iss. 12, pp. 9453-9460
Closed Access | Times Cited: 8
Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy
Safir Ullah Khan, Munir Ullah Khan, Muhammad Suleman, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 4, pp. 265-277
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top